A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.
Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew WL, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C.
Antimicrob Agents Chemother. 2000 Mar;44(3):688-92.PMID: 10681339 [PubMed - indexed for MEDLINE]Related articlesFree article